Oncovirus
Occult hepatitis B virus in liver cancer is uncommon where chronicity is low
Published in Cancer Weekly, September 28th, 2004
According to recent research from the United States, "occult hepatitis B is defined by the presence of hepatitis B viral (HBV) DNA in the serum or liver in persons lacking hepatitis B surface antigen (HBsAg) in the serum. A high prevalence of occult HBV has been reported in hepatocellular carcinoma (HCC) from Asia, but little information is available on the prevalence of occult HBV in HCC from regions with a low prevalence of typical chronic hepatitis B infection."
"In a retrospective study, 19 cases of primary liver cancer were investigated for the presence of occult HBV...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-09-28)
More Articles from Cancer Weekly
- Acute Myeloid Leukemia
Genes linked to AML-associated centrosome aberrations identified - Cancer Therapy
Genes causing inherited cancer can help elucidate chemoresistance - Esophageal Adenocarcinoma
Expression of LAT-1 characterized - Glioma Therapy
Radiochemotherapy regimen feasible for preirradiated patients - Lymphoma Therapy
Rituximab with chemotherapy shows promise for splenic MZL treatment - Adverse Drug Effects
Substance P may play role in hypersensitivity reactions induced by paclitaxel - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
